1. 1200PSerum biomarkers during the first cycle of anti-PD-1 antibody therapies in non-small cell lung cancer. (23rd October 2018) Authors: Ota, T; Takeda, T; Fukui, T; Nakahara, Y; Kudo, K; Okabe, T; Hayashi, H; Otani, S; Hiyoshi, Y; Yonesaka, K; Sugiura, T; Suzumura, T; Terashima, M; Nakano, Y; Hasegawa, Y; Tsukuda, H; Matsui, K; Masuda, N; Fukuoka, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1393PSafety profile and effectiveness of alectinib in the real-world surveillance study of 1251 Japanese patients with ALK-positive non-small cell lung cancer. (23rd October 2018) Authors: Ohe, Y; Yamamoto, N; Gemma, A; Kusumoto, M; Yamada, I; Ishii, T; Masuda, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 151OSingle agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results from a phase I/II trial. (13th May 2019) Authors: Yonemori, K; Masuda, N; Takahashi, S; Kogawa, T; Nakayama, T; Yamamoto, Y; Takahashi, M; Toyama, T; Saeki, T; Iwata, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 184ODistant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial. (23rd October 2018) Authors: Iwata, H; Masuda, N; Yamamoto, Y; Fujisawa, T; Toyama, T; Taira, N; Kashiwaba, M; Ohtani, S; Sakai, T; Hasegawa, Y; Nakamura, R; Akabane, H; Shibahara, Y; Sasano, H; Yamaguchi, T; Ohashi, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 361TiPA phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in elderly patients with advanced stage HER2-positive breast cancer (JCOG1607 HERB TEA study). (23rd October 2018) Authors: Shimomura, A; Tamura, K; Mizutani, T; Shibata, T; Hara, F; Fujisawa, T; Niikura, N; Hojo, T; Kambayashi, C; Saji, S; Masuda, N; Sawaki, M; Yamamoto, N; Nagashima, F; Shien, T; Iwata, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 40OBiomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET). (25th November 2018) Authors: Yap, Y S; Masuda, N; Ito, Y; Ishikawa, T; Kim, S J; Aruga, T; Toyama, T; Saeki, T; Yamanaka, T; Saito, M; Watanabe, J; Takahashi, M; Nakamura, S; Inoue, K; Suarez-Vizcarra, J; He, W; Solovieff, N; Su, F; Chiu, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 42PRibociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC). (25th November 2018) Authors: Masuda, N; Noguchi, S; Ishikawa, T; Aruga, T; Kim, S J; Toyama, T; Saeki, T; Saito, M; Yamanaka, T; Watanabe, J; Nakamura, S; Takahashi, M; Inoue, K; Gounaris, I; Han, Y; Samant, T S; Gazdoiu, M; Ito, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. An adult Japanese Sanfilippo A patient with novel compound heterozygous S347F and D444G mutations in the sulphamidase gene. Issue 6 (1st December 2002) Authors: Miyazaki, T; Masuda, N; Waragai, M; Motoyoshi, Y; Kurokawa, K; Yuasa, T Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 73:Issue 6(2002) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease. Issue 9 (September 1995) Authors: Masuda, N; Goto, J; Murayama, N; Watanabe, M; Kondo, I; Kanazawa, I Journal: Journal of medical genetics Issue: Volume 32:Issue 9(1995) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LBA2_PROverall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Analyses from PALOMA-3. (23rd October 2018) Authors: Cristofanilli, M; Slamon, D J; Ro, J; Bondarenko, I; Im, S-A; Masuda, N; Colleoni, M; DeMichele, A; Loi, S; Verma, S; Iwata, H; Harbeck, N; Loibl, S; André, F; Puyana Theall, K; Huang, X; Giorgetti, C; Huang Bartlett, C; Turner, N C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗